GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Regent Pacific Group Ltd (STU:RPG) » Definitions » Short Interest

Regent Pacific Group (STU:RPG) Short Interest


View and export this data going back to . Start your Free Trial

What is Regent Pacific Group Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Regent Pacific Group's Short Interest

For the Asset Management subindustry, Regent Pacific Group's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regent Pacific Group's Short Interest Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Regent Pacific Group's Short Interest distribution charts can be found below:

* The bar in red indicates where Regent Pacific Group's Short Interest falls into.


Regent Pacific Group (STU:RPG) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Regent Pacific Group Ltd (STU:RPG) » Definitions » Short Interest
Comparable Companies
HKSE:00810 HKSE:00339 HKSE:01160 HKSE:00292 HKSE:00174 HKSE:01217 HKSE:08313 HKSE:02312 HKSE:08030 HKSE:1062 BLK BX KKR OSTO:INVE A APO TSX:BN BK AMP LSE:III XSWX:PGHN
Traded in Other Exchanges
RPGLF:USA 00575:Hong Kong
Address
5 Queen's Road Central, 8th Floor, Henley Building, Hong Kong, HKG
Website
https://www.endurancerp.com
Regent Pacific Group Ltd Formerly Endurance RP Ltd is an investment holding company that runs through two segments: Biopharma and Corporate Investment. Its Biopharma segment is engaged in the research, development, manufacturing, marketing, and sales of pharmaceutical products, and it also develops artificial intelligence (AI) systems for the field of biological aging clocks. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The majority of its revenue comes from the Biopharma segment. Its geographical segments are China, Europe, Hong Kong, and Taiwan.